CQC warns CCGs to be responsible for safe use of controlled drugs

CCGs have been warned by the CQC that they must carry out their responsibility for safe use of controlled drugs to ensure 'valuable intelligence' is not lost as the NHS structure is overhauled.

Mr Behan: 'It is vital that vigilance is maintained to ensure the safety of patients.'
Mr Behan: 'It is vital that vigilance is maintained to ensure the safety of patients.'

Publishing its sixth annual report into the management of controlled drugs, the CQC said attention from CCGs and controlled drugs accountable officers was ‘critical’ if vigilance over controlled drugs was not to be lost during the NHS’s transition period.

From April this year the CQC took over responsibility for assessing governance arrangements for prescribing controlled drugs from PCTs.

The CQC said ‘good progress’ had been made in the past six years on regulations introduced in the wake of Harold Shipman’s murders, and it warned that this must not be lost.

CQC chief executive David Behan, said: ‘As new systems and processes bed in across the NHS it is vital that vigilance is maintained to ensure the safety of patients.

‘It is important and absolutely correct that CQC looks at the governance arrangements for controlled drugs in primary medical services now we are the regulator for these services.’

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register

Already registered?

Sign in

Before commenting please read our rules for commenting on articles.

If you see a comment you find offensive, you can flag it as inappropriate. In the top right-hand corner of an individual comment, you will see 'flag as inappropriate'. Clicking this prompts us to review the comment. For further information see our rules for commenting on articles.

comments powered by Disqus